Trusted by the world’s leading institutions

clients clients clients clients clients clients clients clients clients clients clients
Newswise: Survey reveals growing support for changing Australia Day date
Release date: 24-May-2024 2:05 AM EDT
Survey reveals growing support for changing Australia Day date
University of South Australia

Support for retaining 26 January as Australia’s national day of celebration appears to be slipping, according to a new survey that shows growing numbers of people are open to changing the date out of respect for First Nations people.

Released: 23-May-2024 8:05 PM EDT
Researchers find key differences in brain development between autistic boys and girls
UC Davis MIND Institute

A new study by UC Davis researchers finds key differences in the development of the cortex between autistic boys and girls ages 2-13.

Newswise: Internationally Trained Female Oncologists Face Many Discrimination Challenges in the U.S.
Released: 23-May-2024 7:05 PM EDT
Internationally Trained Female Oncologists Face Many Discrimination Challenges in the U.S.
Sylvester Comprehensive Cancer Center

ASCO: A new study highlights workplace discrimination reported by internationally trained female oncologists. Dr. Coral Olazagasti will present study findings that showed female oncologists reported much higher levels of gender or race/ethnicity-based discrimination than their male counterparts.

Released: 23-May-2024 7:05 PM EDT
Breakthrough in Quantum Computing
Newswise

Quantum computing is on the brink of revolutionizing technology and science. It has, the potential to solve complex problems that are currently beyond the reach of classical computers

Newswise: Quadruple Therapies and the Future of Multiple Myeloma Treatment
Released: 23-May-2024 7:05 PM EDT
Quadruple Therapies and the Future of Multiple Myeloma Treatment
Sylvester Comprehensive Cancer Center

ASCO: Treatment options for multiple myeloma are shifting rapidly, with new patients increasingly being treated with a 4-part drug combination that includes a new immunotherapy agent. What does this mean for patients, and how will treatment change in the future?

Newswise: Rutgers Cancer Institute and RWJBarnabas Health Set to Unveil Extensive, New Cancer Research Findings at 2024 ASCO Annual Meeting
Released: 23-May-2024 6:05 PM EDT
Rutgers Cancer Institute and RWJBarnabas Health Set to Unveil Extensive, New Cancer Research Findings at 2024 ASCO Annual Meeting
Rutgers Cancer Institute

Clinicians and scientists from Rutgers Cancer Institute and RWJBarnabas Health will lead sessions and present their latest discoveries from their innovative cancer research program at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting, to be held in Chicago (and online) from May 30-June 4.

Released: 23-May-2024 6:05 PM EDT
Sylvester Research Shows New Treatment May Enable More Patients With High-Risk Blood Cancers to Receive Stem Cell Transplants
Sylvester Comprehensive Cancer Center

AT ASCO: A new treatment approach using an older drug may enable more patients with high-risk blood cancers to receive transplanted stem cells from unrelated, partially matched donors.

Newswise: Most young women treated for breast cancer can have children, study shows
23-May-2024 1:05 PM EDT
Most young women treated for breast cancer can have children, study shows
Dana-Farber Cancer Institute

New research by Dana-Farber Cancer Institute investigators has encouraging news for young women who have survived breast cancer and want to have children.

23-May-2024 5:00 PM EDT
MD Anderson Research Highlights: ASCO 2024 Special Edition
University of Texas MD Anderson Cancer Center

The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back. This special edition features presentations by MD Anderson researchers at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting.

   
Released: 23-May-2024 4:05 PM EDT
Bioimpressão 3D: Transformando imagens médicas em tecido humano
Mayo Clinic

Pesquisadores da Mayo Clinic estão utilizando a tecnologia para produzir modelos de tecidos de diferentes partes do corpo com o intuito de estudar órgãos e tecidos danificados ou doentes. Eles imaginam o dia em que uma bioimpressora 3D possa moldar células vivas para tratamentos ou curas de distúrbios complexos.


close
1.35073